Mr. Hale has served as a member of our Board since 2013. He is Chairman & CEO of Hale BioPharma Ventures, LLC and a serial entrepreneur who has been involved in the formation and development of a number of life science companies. After positions in sales, marketing and general management at Johnson & Johnson, Inc. and Becton Dickinson, he joined Hybritech, Inc. in 1982, the first biotech company in San Diego. He was President of the company when it was acquired by Eli Lilly & Co. In 1987, he was a co-founder and Chairman of Gensia, Inc. and Viagine, Inc., prior to their sales to Teva Pharmaceuticals and Chiron Inc., respectively.

Mr. Hale has served as Chairman & CEO of CancerVax, and Chairman of Santarus, Micromet, Inc., Crisi Medical Systems, Inc., Biocept, Inc. and Conatus Pharmaceuticals, Inc. He was also co-founder and Chairman of SkinMedica, Inc., Neurelis, Inc., Neurana Pharmaceuticals, Inc. and Agility Clinical, Inc.

Mr. Hale is co-founder and serves on the Board of CONNECT and BIOCOM. He also serves on the Board of the Salk Institute, Rady Children’s Hospital, Rady Children’s Institute of Genomic Medicine and the San Diego Regional Economic Development Council.